Shadow-Mode Evaluation of an AI Assistant for Multidisciplinary Tumor Boards
Key facts
- Who runs it
- Technical University of Munich
- Where
- Germany2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 450 people, planned
- Started
- 9 Nov 2026
- Expected to end
- 30 Apr 2027
- Type of study
- Observational, 3 groups
- Treatments tested
- OnkoBot (shadow mode)
- Record updated
- 16 November 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Case registered for a session of a participating tumor board (hematology, orthopedics and sarcoma, head and neck) of TUM University Hospital rechts der Isar during the study period
- Board registration and pre-board patient documents available before the session starts
Who cannot take part
- Case not discussed at the session, defined as no board report with a consensus decision for that date (deferred or withdrawn registrations)
- Session without a shadow run of the system; Excluded cases are counted and reported by reason
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study tests whether an artificial intelligence (AI) system that drafts tumor board recommendations performs as well on new cases as it did on archived cases. The system runs in shadow mode at three multidisciplinary tumor boards of TUM University Hospital rechts der Isar. For each case it drafts a recommendation before the board meets. The board does not see the draft, and the draft has no influence on patient care. After the meeting, each draft is compared with the board decision. The agreement rate is then compared with the rate measured on archived decisions of the same boards.
The 3 groups in the trial
- Hematology board
Consecutive cases presented at the hematology tumor board of TUM University Hospital rechts der Isar.
Treatment: OnkoBot (shadow mode)
- Orthopedics and sarcoma board
Consecutive cases presented at the orthopedics and sarcoma tumor board of TUM University Hospital rechts der Isar.
Treatment: OnkoBot (shadow mode)
- Head and neck board
Consecutive cases presented at the head and neck tumor board of TUM University Hospital rechts der Isar.
Treatment: OnkoBot (shadow mode)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- OnkoBot: Prospective Shadow-Mode Evaluation of a Locally Operated, Source-Grounded Large Language Model System for Drafting Multidisciplinary Tumor Board Recommendations
- Record updated
- 16 November 2026